Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. CECCATO (Barcelona, Spain), R. Mendez (Valencia, Spain), A. Gabarrus (Barcelona, Spain), C. Agusti (Barcelona, Spain), O. Sibila (Barcelona, Spain), C. Cilloniz (Barcelona, Spain), M. Ferrer (Barcelona, Spain), R. Menendez (Valencia, Spain), J. Bermejo (Valladolid, Spain), A. Torres (Barcelona, Spain). Effect of corticosteroids on inflammatory markers in patients with severe cap and high inflammatory response according to presence of lymphopenia. 2911

Member's Comments

No comment yet.

Related content which might interest you: Expression of stress genes in circulating leucocytes: response to the systemic inflammation in patients with severe pneumonia Source: Eur Respir J 2004; 24: Suppl. 48, 231s Year: 2004 Down-regulation of pro-inflammatory response genes of circulating leukocytes in ICU patients with severe pneumonia meeting criteria of systemic inflammatory response syndrome (SIRS) Source: Eur Respir J 2003; 22: Suppl. 45, 543s Year: 2003 Cellular inflammatory pattern in induced sputum among patients with stable moderate or severe asthma Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010 Systemic inflammatory response in relation to disease severity and nutritional depletion in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 31s Year: 2004 Effects of anti-inflammatory treatment on inflammatory infiltrate and ventilation parameters in patients with moderate COPD Source: Eur Respir J 2007; 30: Suppl. 51, 141s Year: 2007 Severe asthma: from inflammatory phenotype to treatment Source: International Congress 2017 – Chinese Programme 2017 Year: 2017 Dynamic of proinflammatory cytokines system and nonspecific markers of inflammation in patients with COPD before and after treatment with broncholitics Source: Eur Respir J 2006; 28: Suppl. 50, 38s Year: 2006 Markers of severity and inflammatory profile during exacerbations of severe asthma. Source: International Congress 2017 – Airway disease and exacerbations Year: 2017 The effect of augmentation therapy on systemic and pulmonary inflammation markers in α1-antitrypsin deficiency patients Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 Effects of low dose fluticasone/salmeterol on different surrogate inflammatory markers in moderate persistent asthma Source: Eur Respir J 2002; 20: Suppl. 38, 111s Year: 2002 Effect of one moderate or mild exacerbation on lung function and serum inflammatory markers in ex smokers patients with COPD Source: Annual Congress 2009 - Cellular-tissue modifications and functional evaluation in COPD patients Year: 2009 Community-aquired pneumonia: systemic and local inflammatory response in treatment failure Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia Year: 2008 Influence of infection and α1-proteinase inhibitor on inflammatory response in COPD exacerbation Source: Eur Respir J 2003; 22: Suppl. 45, 417s Year: 2003 Impact of treatment on a number of BALF inflammatory cells and cytokines concentrations in patients with moderate COPD Source: Annual Congress 2008 - COPD: from bench to bedside Year: 2008 Severe asthma in old patients is characterized by signs of immunosuppression and by lymphocyte resistance to glucocorticoids Source: Annual Congress 2012 - Aspects of clinical asthma Year: 2012 Distribution of the cellular inflammatory pattern in induced sputum in an eosinophilic severe asthma population. Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Lymphoid follicles in (very) severe COPD: beneficial or harmful? Source: Eur Respir J 2009; 34: 219-230 Year: 2009 Successful treatment of lung inflammation is associated with elevation of lymphocyte sensitivity to glucocorticoids Source: Eur Respir J 2001; 18: Suppl. 33, 433s Year: 2001 Influence of tobacco-smoking and it intensification on systemic inflammatory state (sis) in COPD patients Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 Treatment: how does inflammatory phenotype influence response to treatment in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007